These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7792212)

  • 1. The frequency of erythromycin-resistant Staphylococcus aureus in impetiginized dermatoses.
    Misko ML; Terracina JR; Diven DG
    Pediatr Dermatol; 1995 Mar; 12(1):12-5. PubMed ID: 7792212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains.
    Dagan R; Bar-David Y
    Antimicrob Agents Chemother; 1992 Feb; 36(2):287-90. PubMed ID: 1605593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin-isolated, community-acquired Staphylococcus aureus: in vitro resistance to methicillin and erythromycin.
    Ohana N; Keness J; Verner E; Raz R; Rozenman D; Zuckerman F
    J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):544-6. PubMed ID: 2789236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of antibacterials of Staphylococcus aureus isolated from impetigo patients.
    Nishijima S; Nakagawa M
    J Int Med Res; 1997; 25(4):210-3. PubMed ID: 9283995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impetigo contagiosa: a comparison of erythromycin and dicloxacillin therapy.
    Barton LL; Friedman AD; Portilla MG
    Pediatr Dermatol; 1988 May; 5(2):88-91. PubMed ID: 3045781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal.
    Adhikari RP; Shrestha S; Barakoti A; Amatya R
    BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of josamycin in the treatment of impetigo in children and its in vitro activity on erythromycin resistant Staphylococcus aureus strains.
    Mosca A; Del Prete R; Mazzotta F; Bonifazi E; Miragliotta G
    J Chemother; 1995 Nov; 7 Suppl 4():158-9. PubMed ID: 8904141
    [No Abstract]   [Full Text] [Related]  

  • 8. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.
    Alsterholm M; Flytström I; Bergbrant IM; Faergemann J
    Acta Derm Venereol; 2010; 90(1):52-7. PubMed ID: 20107726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial skin infections at a tertiary dermatological centre.
    Tan HH; Tay YK; Goh CL
    Singapore Med J; 1998 Aug; 39(8):353-6. PubMed ID: 9844495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin.
    Barton LL; Friedman AD; Sharkey AM; Schneller DJ; Swierkosz EM
    Pediatr Dermatol; 1989 Jun; 6(2):134-8. PubMed ID: 2501775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of impetigo.
    Coskey RJ; Coskey LA
    J Am Acad Dermatol; 1987 Jul; 17(1):62-3. PubMed ID: 3611455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
    Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
    Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-year study of impetigo in Sydney.
    Rogers M; Dorman DC; Gapes M; Ly J
    Med J Aust; 1987 Jul; 147(2):63-5. PubMed ID: 3299015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-resistant Staphylococcus aureus in community-acquired pediatric neck abscesses.
    Guss J; Kazahaya K
    Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):943-8. PubMed ID: 17418426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impetigo: a reassessment of etiology and therapy.
    Barton LL; Friedman AD
    Pediatr Dermatol; 1987 Nov; 4(3):185-8. PubMed ID: 3122189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of Staphylococcus aureus resistance to erythromycin in Denmark, 1959 to 1988: comparison with erythromycin-susceptible strains.
    Westh H; Knudsen AM; Gottschau A; Rosdahl VT
    J Hosp Infect; 1991 May; 18(1):23-34. PubMed ID: 1679069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies.
    Demidovich CW; Wittler RR; Ruff ME; Bass JW; Browning WC
    Am J Dis Child; 1990 Dec; 144(12):1313-5. PubMed ID: 2244610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Centre, Singapore.
    Goh CL; Wong JS; Giam YC
    Int J Dermatol; 1997 Sep; 36(9):653-7. PubMed ID: 9352404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence for mutation to erythromycin resistance in clinical strains of Staphylococcus aureus.
    Lacey RW
    J Clin Pathol; 1977 Jul; 30(7):602-5. PubMed ID: 886013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.